In December 2025, Lucy J Robertshaw AB, working in collaboration with the Hong Kong Chamber of Commerce in Sweden (HKCCSE), led a curated Nordic Life Science delegation to Hong Kong.
The delegation brought together a small group of Swedish life science companies with key stakeholders across Hong Kong’s clinical, innovation and industry ecosystem, with a focus on practical collaboration rather than introductory meetings.
Objectives
- Provide Nordic companies with first-hand insight into Hong Kong as a gateway to Asia
- Facilitate relevant, high-quality meetings through trusted networks
- Explore concrete pathways for clinical collaboration, market entry and scaling
Participants
The delegation included organisations across biotech, MedTech, digital health and innovation support, including:
NextCell Pharma,
SampleFacts,
Veltio Pharma,
Uppsala Innovation Centre
Heitner Biopharm Consultation.
Delivery
Lucy led the design, coordination and on-site facilitation of the programme, working closely with HKCCSE as a platform and convenor to engage relevant partners and stakeholders.
Outcomes
- Clearer understanding of Hong Kong’s clinical and regulatory landscape
- Identification of follow-on collaboration and pilot opportunities
- Strengthened Nordic–Hong Kong relationships anchored through the Chamber
The delegation now serves as a foundation for continued Nordic–Asia life science collaboration, including future delegations, partnerships and exchange initiatives.
